HomeCompareSILX vs JNJ

SILX vs JNJ: Dividend Comparison 2026

SILX yields 114.29% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SILX wins by $6.85M in total portfolio value
10 years
SILX
SILX
● Live price
114.29%
Share price
$1.75
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.87M
Annual income
$2,525,010.49
Full SILX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SILX vs JNJ

📍 SILX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSILXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SILX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SILX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SILX
Annual income on $10K today (after 15% tax)
$9,714.29/yr
After 10yr DRIP, annual income (after tax)
$2,146,258.92/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SILX beats the other by $2,145,555.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SILX + JNJ for your $10,000?

SILX: 50%JNJ: 50%
100% JNJ50/50100% SILX
Portfolio after 10yr
$3.45M
Annual income
$1,262,919.14/yr
Blended yield
36.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SILX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SILX buys
0
JNJ buys
0
No recent congressional trades found for SILX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSILXJNJ
Forward yield114.29%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$6.87M$20.0K
Annual income after 10y$2,525,010.49$827.78
Total dividends collected$6.22M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SILX vs JNJ ($10,000, DRIP)

YearSILX PortfolioSILX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$22,129$11,428.57$10,676$355.77+$11.5KSILX
2$47,313$23,635.32$11,407$389.39+$35.9KSILX
3$97,853$47,228.47$12,198$426.53+$85.7KSILX
4$195,991$91,288.48$13,056$467.62+$182.9KSILX
5$380,592$170,881.10$13,987$513.12+$366.6KSILX
6$717,355$310,122.08$14,998$563.56+$702.4KSILX
7$1,313,861$546,290.58$16,098$619.52+$1.30MSILX
8$2,340,924$935,093.23$17,295$681.69+$2.32MSILX
9$4,061,863$1,557,073.54$18,599$750.82+$4.04MSILX
10$6,871,204$2,525,010.49$20,022$827.78+$6.85MSILX

SILX vs JNJ: Complete Analysis 2026

SILXStock

The index tracks the performance of the equity securities of small-capitalization companies actively engaged in silver refining, mining, or exploration (“Junior Silver Companies”). The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. It is non-diversified.

Full SILX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SILX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SILX vs SCHDSILX vs JEPISILX vs OSILX vs KOSILX vs MAINSILX vs ABBVSILX vs MRKSILX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.